rs139522696
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_030962.4(SBF2):āc.3831C>Gā(p.Ile1277Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00029 in 1,614,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_030962.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152174Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000215 AC: 54AN: 251302Hom.: 0 AF XY: 0.000199 AC XY: 27AN XY: 135836
GnomAD4 exome AF: 0.000299 AC: 437AN: 1461860Hom.: 0 Cov.: 31 AF XY: 0.000286 AC XY: 208AN XY: 727230
GnomAD4 genome AF: 0.000204 AC: 31AN: 152174Hom.: 0 Cov.: 31 AF XY: 0.000175 AC XY: 13AN XY: 74350
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
- -
- -
SBF2: BP4 -
Observed in patient with peripheral neuropathy in published literature; however, a second variant was not identified (PMID: 25025039); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 24290377, 25025039) -
Charcot-Marie-Tooth disease type 4B2 Uncertain:3
The SBF2 c.3831C>G; p.Ile1277Met variant (rs139522696), has been reported in the heterozygous state in individuals affected with CMT and in a control individual (Hoyer 2014). However, the p.Ile1277Met variant was not predicted to be associated with CMT. This variant is found in the general population with an overall allele frequency of 0.02 % (60/ 282,692 alleles) in the Genome Aggregation Database. The isoleucine at codon 1277 is moderately conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. However, given the lack of clinical and functional data, the significance of the p.Ile1277Met variant is uncertain at this time. -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
- -
not specified Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.3831C>G (p.I1277M) alteration is located in exon 29 (coding exon 29) of the SBF2 gene. This alteration results from a C to G substitution at nucleotide position 3831, causing the isoleucine (I) at amino acid position 1277 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Charcot-Marie-Tooth disease type 4 Uncertain:1
This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 1277 of the SBF2 protein (p.Ile1277Met). This variant is present in population databases (rs139522696, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with SBF2-related conditions. ClinVar contains an entry for this variant (Variation ID: 246374). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SBF2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at